Our study indicated for the first time that knockdown of PGAM1 could reconstruct the expression of ASS1 in BC cells, resulting in a decrease in tumor growth and exerting antitumor effects via cAMP/AMPK/CEBPB axis. The gene discussed is CEBPB; the disease is breast cancer.